发明名称 New fused-ring di:hydro-pyridine-acetic acid derivs. - useful as cardio-protective and cerebro-protective agents, antiinflammatory agents and anticoagulants or platelet aggregation inhibitors
摘要 Fused-ring dihydropyridine acetic acid derivs. of formula (I) and their acid-addn. salts are new. A = benzo, thieno or indolo (also pyrrolo in disclosure); when A = benzo, m = 2 and R11 = OH, 1-4C alkoxy, mesyloxy or NHSO2Me, or adjacent R11+R11 = OCH2O or OCH2CH2O (M and R11 are not otherwise defined); R1 = 4-6C cycloalkyl or (4-6C)cycloalkyl(1-5C)alkyl, or when A = pyrrolo, R1 may also be H, 1-10C alkyl, phenyl(1-5C)alkyl, 1-4C alkoxy or NHCOX (X - 1-5C alkyl); R2 and R3 = H or 1-5C alkyl, or CR2R3 is a 5- or 6-membered carbocyclic ring; R5 = H or 1-4C alkyl; R4 = 1-4C alkoxy or NR9R10; R9 and R10 = H, 3-6C alkenyl, 3-6C alkynyl, or 1-12C alkyl opt. substd. by OH, 1-4C alkoxy, di(1-4C alkyl)amino, furyl, pyridyl, pyrrolidinyl, morpholino, indolyl, CN, thienyl or phenyl (opt. substd. by OH, OMe, F, NHSO2Me, mesyloxy or OCH2O); or R9 = H and R10 = phenyl, fluorophenyl, pyridyl or N-benzylpiperidyl; or NR9R10 = pyrrolidino, piperidino, morpholino or 1-piperazinyl opt. 4-substd. by Me, Ph, mono- or di(1-4C alkoxy)phenyl, pyrimidinyl or phenyl(1-4C)alkyl. A typical cpd. is 3,4-dihydro-6,7-dimethoxy-alpha- cyclohexyl-N-(2- methoxybenzyl)-isoquinoline-1-acetamide. HCl, m.pt. 116-127 deg. C. USE/ADVANTAGE - (I) are cardioprotective and cerebroprotective agents, antiinflammatory agents (e.g. for treating asthma and arthritis), and anticoagulants or platelet aggregation inhibitors.
申请公布号 DE4220368(A1) 申请公布日期 1993.12.23
申请号 DE19924220368 申请日期 1992.06.22
申请人 BOEHRINGER INGELHEIM KG, 55218 INGELHEIM, DE 发明人 ARNDTS, DIETRICH, DR., 6531 APPENHEIM, DE;LOESEL, WALTER, DIPL.-CHEM. DR., 6535 GAU-ALGESHEIM, DE;ROOS, OTTO, DIPL.-CHEM. DR., 6501 SCHWABENHEIM, DE
分类号 C07D217/14;C07D217/18;C07D401/12;C07D405/12;C07D409/12;C07D471/04;C07D487/04;C07D491/04;C07D495/04;(IPC1-7):C07D217/12;C07D217/16;A61K31/44;A61K31/47;A61K31/645 主分类号 C07D217/14
代理机构 代理人
主权项
地址
您可能感兴趣的专利